Preclinical and clinical studies have highlighted mitochondrial impairment, enhanced oxidative stress, disrupted insulin signaling in the central nervous system, and impaired synaptic plasticity as key elements linking metabolic dysregulation to cognitive decline [141]. This evidence concerns the gene INS and Mental deterioration.